These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11932 related articles for article (PubMed ID: 11327538)

  • 1. Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton.
    Jantová S; Urbancíková M; Maliar T; Mikulásová M; Rauko P; Cipák L; Kubíková J; Stankovský S; Spirková K
    Neoplasma; 2001; 48(1):52-60. PubMed ID: 11327538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH-3T3 cells.
    Jantová S; Letasiová S; Repický A; Ovádeková R; Lakatos B
    Cell Biochem Funct; 2006; 24(6):519-30. PubMed ID: 16342136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines.
    Jantová S; Theiszová M; Mikulásová M
    Neoplasma; 2004; 51(6):436-41. PubMed ID: 15640952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
    Jantová S; Letasiová S; Ovádeková R; Múcková M
    Neoplasma; 2006; 53(4):291-300. PubMed ID: 16830055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative activity and apoptosis induced by 6-bromo-2-(morpholin-1-yl)-4-anilinoquinazoline on cells of leukemia lines.
    Jantova S; Repicky A; Paulovicova E; Letasiova S; Cipak L
    Exp Oncol; 2008 Jun; 30(2):139-42. PubMed ID: 18566578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and detection of damage to DNA by 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c] quinazoline on human cancer cell line HeLa.
    Ovádeková R; Jantová S; Theiszová M; Labuda J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):455-9. PubMed ID: 16601809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferation activity and the mechanism of action of 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline--potential anticancer drug.
    Jantová S; Ruzeková L; Stankovský S; Spirková K
    Neoplasma; 1997; 44(4):240-6. PubMed ID: 9473777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
    Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
    Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
    J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
    Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
    Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumoral activity of new pyrimidine derivatives of sesquiterpene lactones.
    Quintero A; Pelcastre A; Solano JD
    J Pharm Pharm Sci; 1999; 2(3):108-12. PubMed ID: 10953257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
    Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
    J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of novel 6-Arylbenzimidazo[1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion.
    Galarce GD; Foncea RE; Edwards AM; Pessoa-Mahana H; Pessoa-Mahana CD; Ebensperger RA
    Biol Res; 2008; 41(1):43-50. PubMed ID: 18769762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic sesquiterpenes from Aplysia dactylomela.
    Dias T; Brito I; Moujir L; Paiz N; Darias J; Cueto M
    J Nat Prod; 2005 Nov; 68(11):1677-9. PubMed ID: 16309323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of phenothiazine-related compounds.
    Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells.
    González Borroto JI; Pérez Machado G; Creus A; Marcos R
    Mutagenesis; 2005 May; 20(3):193-7. PubMed ID: 15817571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 597.